大象传媒

Home
Faculty of Medicine

News archive for Faculty of Medicine

Cornelia Schuster defended 22.11.2016 her dissertation "Investigation of predictive markers in patients with metastatic melanoma treated with bevacizumab" at the University of Bergen.
Prof. Kamal Mustafa and his research team from the Department of Clinical Dentistry were awarded the prize by BTO and Sparebanken Vest.
Lavina Ahmed defended Wednesday November 2nd 2016 her dissertation 芦Axl as a Biomarker in Breast and Lung Cancer禄 at the University of Bergen.
- The aim of the Research School is to increase network activity between Ph.D.-candidates, thereby lowering the threshold to visit each other and cooperate, says Chairman Thorkild Tyllesk盲r. 鈥揥e believe that through this we will be able to facilitate for better research.
The Norwegian Forum for Global Health Research began almost exactly 10 years ago, 16 November 2006. A group from Forum and other global health-interested met in Troms酶 3-4 November, 2016.
Auroras work at USC highlighted in the J1 Newsletter.
The research group held a seminar on Mental health and child and adolescent health programs in Cambodia and South-East-Asia in October.
G酶ril Knutsvik defended Monday October 31st 2016 her thesis 鈥滲iomarkers in breast cancer, with special focus on tumor cell proliferation鈥 for the PhD degree at the University of Bergen.
Professor Jan Haavik has been given the Helse Vest Research award 2016 for his research on discovering biological mechanisms that can cause ADHD-symptoms. He was rewarded the prize during the annual research conference of Helse Vest.
There are two main reasons for why J酶rn Blume is the candidate of the month of July.
Welcome to the mini-seminar 3rd of November in Aud. 2, BBB, 1330-1530 and the inauguration of MICs new Confocal/STED microscope: Leica TCS SP8 STED 3X
Caroline Engen is a CCBIO PhD candidate who presented at the S.Net conference in Bergen. Her lecture was titled "Why Targeted Therapy May Not Work", and was part of the CCBIO session "The Transition from a Blockbuster Model to Personalised Cancer Therapy". We asked Caroline to walk us through a medical researcher's perspective of the conference and the use of new technologies.
The status of safety conditions in many countries is changeable.

Pages